Literature DB >> 9039653

Kainate/AMPA receptors expressed on human fetal astrocytes in long-term culture.

K Cauley1, V Kukekov, D Young.   

Abstract

Long-term cultivation of primary human fetal brain cells has yielded a homogeneous population of glial progenitors of extended life span. These human astrocyte precursor (HAP-1) cells have been in culture for greater than 1 year, are diploid, and do not form colonies in soft agar. The culture was established in 10% fetal calf serum (FCS), although cells greatly increase their proliferative rate when both basic fibroblast growth factor and FCS are present in the culture media. HAP-1 cells express the cytoskeletal proteins glial fibrillary acidic protein, vimentin, and nestin. HAP-1 cells express the AMPA/kainate receptor subunit genes GluRs 1, 3, and 4 and the kainate receptor subunit genes GluR6, KA1, and KA2. Immunohistochemistry confirms the expression of GluR subunit proteins. HAP-1 cells demonstrate a kainate-responsive current found to be blockable by CNQX. HAP-1 cells will serve in the study of human glial cells and ligand-gated ion channels and in the identification of compounds which might act as agonists or antagonists at these receptor-ion channel complexes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039653     DOI: 10.1002/(sici)1097-4547(19970201)47:3<311::aid-jnr9>3.0.co;2-l

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  2 in total

1.  Simvastatin, edaravone and dexamethasone protect against kainate-induced brain endothelial cell damage.

Authors:  Lilla Barna; Fruzsina R Walter; András Harazin; Alexandra Bocsik; András Kincses; Vilmos Tubak; Katalin Jósvay; Ágnes Zvara; Patricia Campos-Bedolla; Mária A Deli
Journal:  Fluids Barriers CNS       Date:  2020-02-10

Review 2.  Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.

Authors:  Falko Lange; Julia Hörnschemeyer; Timo Kirschstein
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.